GPT Healthcare Limited is engaged in the business of providing healthcare services. The company operates a chain of mid-sized full service hospitals under the brand and provides integrated healthcare services, with a focus on secondary and tertiary care. The Principal activities of the company include operation of multidisciplinary private hospitals and pharmacies. It offers a comprehensive range of healthcare services across many specialties and super specialties, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics and neonatology.

GPT Healthcare major competitors are KMC Speciality Hosp, Suraksha Diagnostic, Shalby, Dr Agarwals Eye Hsp, Krsnaa Diagnostics, Asarfi Hospital Ltd., Unihealth Hospitals.
Market Cap of GPT Healthcare is ₹1,232 Crs.
While the median market cap of its peers are ₹1,737 Crs.

GPT Healthcare seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.